Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ARMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ARMP

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Armata Pharmaceuticals Inc

ARMP
Current price
2.42 USD +0.05 USD (+2.11%)
Last closed 2.36 USD
ISIN US04216R1023
Sector Healthcare
Industry Biotechnology
Exchange NYSE
Capitalization 82 159 248 USD
Yield for 12 month -19.87 %
1Y
3Y
5Y
10Y
15Y
ARMP
21.11.2021 - 28.11.2021

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc. Address: 5005 McConnell Avenue, Los Angeles, CA, United States, 90066

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

9.00 USD

P/E Ratio

Dividend Yield

Financials ARMP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ARMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+5 174 000 USD

Last Year

+4 529 000 USD

Current Quarter

Last Quarter

+1 235 000 USD

Current Year

+3 849 000 USD

Last Year

-29 241 000 USD

Current Quarter

Last Quarter

+855 000 USD
EBITDA -39 014 000 USD
Operating Margin TTM -1 668.23 %
Price to Earnings
Return On Assets TTM -24.32 %
PEG Ratio
Return On Equity TTM -3 439.35 %
Wall Street Target Price 9.00 USD
Revenue TTM 4 699 000 USD
Book Value -1.49 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -49.20 %
Dividend Yield
Gross Profit TTM -27 140 000 USD
Earnings per share -0.40 USD
Diluted Eps TTM -0.40 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -9.07 %

Stock Valuation ARMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 148.14
Price Sales TTM 17.48
Enterprise Value EBITDA 15.08
Price Book MRQ 2.11

Technical Indicators ARMP

For 52 Weeks

0.90 USD 3.42 USD
50 Day MA 1.84 USD
Shares Short Prior Month 4 179
200 Day MA 1.97 USD
Short Ratio 0.21
Shares Short 134 133
Short Percent 1.27 %